CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 663 participants.

Also called NCT07276711

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 663 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07276711
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07276711. Randomized; single masking; primary purpose treatment. Start 2026-05-12 (actual); primary completion 2028-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
Condition
Aortic Valve Stenosis
Condition
Aortic Stenosis
Condition
Aortic Valve Disease
Intervention (Device)
EmStop Embolic Protection System
Intervention (Device)
Boston Scientific Sentinel
Lead sponsor
EmStop Inc (class: industry)
Collaborator
Bright Research Partners (class: industry)

Record details

Record id
cardio:ct-nct07276711
Content hash
476c01bc40bab0efe7160d5324d3a470433fed4903ac410d78d56d8e62f90c9f